儿科提供者对静脉血栓栓塞与出血风险相对临床重要性的国际调查
该国际调查由ISTH SSC儿科与新生儿血栓与止血小组委员会发起,采用横断面问卷结合病例情景和Likert量表,评估儿科提供者在不同严重程度医院获得性静脉血栓栓塞(HA-VTE)与抗凝预防出血风险之间的权衡。结果显示,除轻微出血外,提供者预防非严重HA-VTE的意愿较低,但仅婴儿年龄使评分变化≥1分。
要点
- 除轻微出血外,儿科提供者预防非严重HA-VTE的意愿低于预防伴血流动力学损害的肺栓塞。
- HA-VTE类型、出血特征及患者特征(尤其婴儿年龄)影响预防决策,但变化幅度很小。
- 仅婴儿年龄与提供预防意愿评分变化≥1分相关。
核心结论
- 儿科提供者可接受的出血风险随感知的HA-VTE严重程度而变化。
- 特定特征尤其是婴儿年龄会改变决策,尽管已明确出血风险。
研究设计与样本
- 横断面国际调查,对象为儿科提供者。
- 使用病例情景和Likert量表,量化预防4种严重程度不同的HA-VTE的意愿,设定6种出血特征风险相等。
- 每个情景中位应答人数为145(IQR 139-152)。
主要发现
- 除轻微出血外,受访者预防非严重HA-VTE的意愿较低,但伴血流动力学损害的肺栓塞除外。
- HA-VTE类型、出血特征和患者特征(尤其婴儿年龄)与预防意愿评分变化相关。
- 评分变化总体很小,仅婴儿年龄与变化≥1分相关。
临床怎么用
- 研究结果可为临床和未来研究中权衡HA-VTE与出血竞争风险提供半定量方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the absence of robust data, the decision to provide primary pharmacologic thromboprophylaxis in hospitalized children depends on the perceived risks of hospital-acquired venous thromboembolism (HA-VTE), balanced against the acceptable bleeding risk from thromboprophylaxis. OBJECTIVES: We aimed (1) to determine the perceived relative clinical significance of HA-VTE and bleeding from thromboprophylaxis among pediatric providers, and (2) to determine patient and provider characteristics that modify this perception. METHODS: We conducted a cross-sectional survey among pediatric providers. Using case vignettes and Likert scales, we quantified the likelihood of providing thromboprophylaxis to prevent 4 types of HA-VTE, varying in severity, given equal risks of developing 6 bleeding characteristics, ranging from minor to fatal. We evaluated 9 patient characteristics, including patient age, and 7 provider characteristics that may modify this decision. RESULTS: A median of 145 (IQR, 139-152) respondents answered each vignette. For all bleeding characteristics other than minor bleeding, respondents were less likely to provide thromboprophylaxis to prevent nonsevere HA-VTE, except for pulmonary embolism with hemodynamic compromise. HA-VTE type, bleeding, and patient characteristics, particularly infant age, were associated with a change in scores in the likelihood of providing thromboprophylaxis. However, changes were minimal, with only infant age associated with a change of ≥1 point. CONCLUSION: Among pediatric providers, the acceptable bleeding risk for primary pharmacologic thromboprophylaxis varies with perceived HA-VTE severity. Specific features, particularly infant age, modified the respondents' decisions despite the stated risks. Our findings can provide a robust, semiquantitative approach to address these competing risks clinically and in future research.
引用
- Huibonhoa RMT, Raffini L, Sochet AA, et al. Perceived relative clinical significance of the risks of venous thromboembolism and bleeding from pharmacologic thromboprophylaxis in children: an international survey of pediatric providers: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. J Thromb Haemost. 2025. PMID: 41422945. doi:10.1016/j.jtha.2025.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。